Trial
NCT03560011
Efficacy and Safety of Immunoglobulin Associated With Rituximab Versus Rituximab Alone in Childhood-Onset Steroid-dependent Nephrotic Syndrome
Phase IISUSPENDEDSAFETYConfidence: MEDIUM
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Steroid-Dependent Nephrotic Syndrome
Intervention
immunoglobulin IV
Why stopped
Decision of Data Safety Monitoring Board
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-04